193 related articles for article (PubMed ID: 28527968)
21. Antigenic phenotype of lung carcinomas: usual spectrum of distribution of thyroid transcription factor-1, cytokeratin 7, cytokeratin 20, and neuron specific enolase--basic immunohistochemical study of 21 cases.
Kostovski M; Petrushevska G
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):199-207. PubMed ID: 24798606
[TBL] [Abstract][Full Text] [Related]
22. The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.
Li L; Li X; Yin J; Song X; Chen X; Feng J; Gao H; Liu L; Wei S
PLoS One; 2014; 9(7):e100837. PubMed ID: 25003505
[TBL] [Abstract][Full Text] [Related]
23. Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids.
Gomez-Fernandez C; Jorda M; Delgado PI; Ganjei-Azar P
Cancer; 2002 Oct; 96(5):289-93. PubMed ID: 12378596
[TBL] [Abstract][Full Text] [Related]
24. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
25. Thyroid transcription factor 1 represses the expression of Ki-67 and induces apoptosis in non-small cell lung cancer.
Zu YF; Wang XC; Chen Y; Wang JY; Liu X; Li X; Li CW; Xie YC; Luo Y; Shang XQ; Guo J
Oncol Rep; 2012 Nov; 28(5):1544-50. PubMed ID: 22940844
[TBL] [Abstract][Full Text] [Related]
26. Expression of thyroid transcription factor-1 in malignant pleural effusions.
Khoor A; Byrd-Gloster AL; Nicosia SV
Pathol Oncol Res; 2011 Jun; 17(2):263-7. PubMed ID: 20848248
[TBL] [Abstract][Full Text] [Related]
27. Cytomorphologic overlap of differentiated thyroid carcinoma and lung adenocarcinoma and diagnostic value of TTF-1 and TGB on cytologic material.
Sathiyamoorthy S; Maleki Z
Diagn Cytopathol; 2014 Jan; 42(1):5-10. PubMed ID: 23637102
[TBL] [Abstract][Full Text] [Related]
28. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas.
Moldvay J; Jackel M; Bogos K; Soltész I; Agócs L; Kovács G; Schaff Z
Pathol Oncol Res; 2004; 10(2):85-8. PubMed ID: 15188024
[TBL] [Abstract][Full Text] [Related]
29. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
Ng WK; Chow JC; Ng PK
Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
[TBL] [Abstract][Full Text] [Related]
30. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
Al-Zahrani IH
Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
[TBL] [Abstract][Full Text] [Related]
31. Thyroid transcription factor-1 in primary CNS tumors.
Kristensen MH; Nielsen S; Vyberg M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):437-43. PubMed ID: 21325940
[TBL] [Abstract][Full Text] [Related]
32. Thyroid transcription factor 1 in pulmonary adenocarcinoma.
Stenhouse G; Fyfe N; King G; Chapman A; Kerr KM
J Clin Pathol; 2004 Apr; 57(4):383-7. PubMed ID: 15047742
[TBL] [Abstract][Full Text] [Related]
33. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
Zamecnik J; Kodet R
Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
[TBL] [Abstract][Full Text] [Related]
34. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M
Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909
[TBL] [Abstract][Full Text] [Related]
35. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
Kim JH; Kim YS; Choi YD; Lee JS; Park CS
Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of estrogen receptor in pulmonary adenocarcinoma.
Lau SK; Chu PG; Weiss LM
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):83-7. PubMed ID: 16540736
[TBL] [Abstract][Full Text] [Related]
37. [Expression and clinical significance of the thyroid transcription factor 1 in Xuanwei lung adenocarcinoma].
Zu Y; Wang X; Liu X; Chen Y; Li C; Shang X; Xie Y; Zhao H; Wang J
Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):131-7. PubMed ID: 23514941
[TBL] [Abstract][Full Text] [Related]
38. Role of thyroid transcription factor-1 and P63 immunocytochemistry in cytologic typing of non-small cell lung carcinomas.
Sinna EA; Ezzat N; Sherif GM
J Egypt Natl Canc Inst; 2013 Dec; 25(4):209-18. PubMed ID: 24207093
[TBL] [Abstract][Full Text] [Related]
39. Different cutoff values for thyroid transcription factor-1 antibodies in the diagnosis of lung adenocarcinoma.
Smits AJ; Vink A; Tolenaars G; Herder GJ; Kummer JA
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):416-21. PubMed ID: 25356948
[TBL] [Abstract][Full Text] [Related]
40. Dual surrogate markers for rapid prediction of epidermal growth factor receptor mutation status in advanced adenocarcinoma of the lung: A novel approach in resource-limited setting.
Udupa KS; Rajendranath R; Sagar TG; Sundersingh S; Joseph T
Indian J Cancer; 2015; 52(3):266-8. PubMed ID: 26905105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
